nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Announcement
|
Pestell, Katharine |
|
2003 |
24 |
11 |
p. 559- 1 p. |
artikel |
2 |
Anthrax mounts a nuclear attack on glucocorticoid signaling
|
Kliewer, Steven A |
|
2003 |
24 |
11 |
p. 558-559 2 p. |
artikel |
3 |
cNOS–iNOS paradigm and arginase in asthma
|
Ricciardolo, Fabio L.M |
|
2003 |
24 |
11 |
p. 560-561 2 p. |
artikel |
4 |
Contents page + Editorial Board
|
|
|
2003 |
24 |
11 |
p. i- 1 p. |
artikel |
5 |
Divergence and complexities in DAG signaling: looking beyond PKC
|
Yang, ChengFeng |
|
2003 |
24 |
11 |
p. 602-608 7 p. |
artikel |
6 |
Leading the charge – pioneering treatments in the fight against neuropathic pain
|
Dickinson, Tracey |
|
2003 |
24 |
11 |
p. 555-557 3 p. |
artikel |
7 |
Neuroadaptive effects of active versus passive drug administration in addiction research
|
Jacobs, Edwin H |
|
2003 |
24 |
11 |
p. 566-573 8 p. |
artikel |
8 |
Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders
|
Holmes, Andrew |
|
2003 |
24 |
11 |
p. 580-588 9 p. |
artikel |
9 |
RAMPs: 5 years on, where to now?
|
Morfis, Maria |
|
2003 |
24 |
11 |
p. 596-601 6 p. |
artikel |
10 |
Response to Mousavizadeh et al.: Oxidative toxicity and glutamate excitotoxicity in multiple sclerosis
|
Neuhaus, Oliver |
|
2003 |
24 |
11 |
p. 564-565 2 p. |
artikel |
11 |
Response to Ricciardolo: The functional significance of arginase in asthma is supported by gene expression
|
Meurs, Herman |
|
2003 |
24 |
11 |
p. 562-563 2 p. |
artikel |
12 |
Targeting thrombin – rational drug design from natural mechanisms
|
Huntington, James A |
|
2003 |
24 |
11 |
p. 589-595 7 p. |
artikel |
13 |
The annexin 1 receptor(s): is the plot unravelling?
|
Perretti, Mauro |
|
2003 |
24 |
11 |
p. 574-579 6 p. |
artikel |
14 |
Uric acid: a novel treatment strategy for multiple sclerosis
|
Mousavizadeh, Kazem |
|
2003 |
24 |
11 |
p. 563-564 2 p. |
artikel |